Dear Creators, we are proud to announce an amazing affiliate program for you to earn some serious and continual cash. Read about our affiliate progarm here.
Caros criadores, temos o orgulho de anunciar um incrível programa de afiliados para vocês ganharem muito dinheiro de forma contínua. Leia sobre nosso programa de afiliados aqui.
Spike clotting in vaccinated vs unvaccinated (abnormal clots episode 7 - update 100)
After an extensive analysis of spike protein-related clot formation, scientists have provided us with the long-awaited first clue. We now shift our focus towards investigating the occurrence of clots in different groups: unvaccinated individuals versus those who have received the COVID-19 vaccination, as well as healthy controls versus patients with chronic fatigue syndrome. <br> <br> <br>Location: Sarrail ridge, Alberta <br> <br> <br>Described content: <br>Vaxx vs unvaxx clotting: https://www.mdpi.com/1424-8247/15/8/931 <br> <br> <br>Long COVID and ME/CFS summit: https://living-from-inspiratio....n.mykajabi.com/sched <br> <br> <br>Supplements survey: https://docs.google.com/forms/....d/e/1FAIpQLSfGz3rcVB <br> <br> <br>__________________________________________________________________ <br>Dr. Raszek Credentials: https://merogenomics.ca/en/about/ <br>____________________________________________________________________ <br> <br>Please stay in touch with us on other social media channels: <br> <br>Twitter: https://twitter.com/merogenomics <br>Facebook: https://www.facebook.com/merogenomics/ <br>Blog: https://merogenomics.ca/blog/ <br> <br>It has come to our attention that our sign up page has been reported as unsafe! We believe this to be a malicious attack. We are waiting for Microsoft to come to their senses and remove the inappropriate warning. <br> <br>Alternate Newsletter sign up: http://eepurl.com/hesNGf <br>Original Newsletter sign up (safe!): https://share.ebforms.com/5371824348594176 <br> <br>Instagram: https://www.instagram.com/merogenomics <br>Patreon: https://www.patreon.com/merogenomics
SORT BY-
Top Comments
-
Latest comments